Stuttgart - Delayed Quote EUR

AbbVie Inc (4AB.SG)

151.80

+2.60

+(1.74%)

As of 8:00:11 AM GMT+2. Market Open.

AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now

We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]

Insider Monkey 18 hours ago

ABBV

^GSPC
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).

StockStory yesterday

ABBV

BMRN

MRNA
The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment

AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment are included in this Analyst Blog.

Zacks yesterday

ABBV

ENZ

CVV
Top Research Reports for AbbVie, TJX & Charles Schwab

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX) and The Charles Schwab Corporation (SCHW), as well as two micro-cap stocks, Enzo Biochem, Inc. (ENZ) and CVD Equipment Corporation (CVV).

Zacks yesterday

ABBV

SCHW

TJX
AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In

We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring […]

Insider Monkey yesterday

ABBV
The Zacks Analyst Blog Merck and AbbVie

Merck and AbbVie are included in this Analyst Blog.

Zacks yesterday

ABBV
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?

Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.

Zacks 2 days ago

ABBV

MRK
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis

AbbVie's, Rinvoq and AstraZeneca's and Novartis are included in this Analyst Blog.

Zacks 3 days ago

NVS

AZN

ABBV
Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?

We recently published a list of Long-Term Stock Portfolio: 15 Best Stocks for 15 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks for 15 years. Russell Investments believes that 3 features are defining the market outlook for 2025. These include the elevated level […]

Insider Monkey 3 days ago

ABBV
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

EU approves expanded use of ABBV's Rinvoq and AZN's Imfinzi and Enhertu. NVS set to invest $23B to boost U.S. manufacturing.

Zacks 5 days ago

AZN

ABBV

NVS
Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. First quarter of 2025 witnessed sharp equities sell off due to the shift out of mega caps. There was a relative outperformance of mid cap growth stocks over large and […]

Insider Monkey 5 days ago

ABBV
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.

Investor's Business Daily 6 days ago

MRK

BMY

CELG-RT
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks 6 days ago

ABBV
Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Pharma names whipsawed Wednesday after Trump said he would enact "major" tariffs on drug imports and then backed off his tariffs — for now.

Investor's Business Daily 7 days ago

ABBV

LLY

MRK
Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs

Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, signaling the industry could be next in line amid a trade war that is causing market turmoil. AbbVie, Eli Lilly, Johnson & Johnson, Merck and Pfizer were all down at least 2.5% in Wednesday midday trading. Denmark's Novo Nordisk, Switzerland's Novartis and the U.K.'s AstraZeneca and GSK fell 2% or more in the U.S.

The Wall Street Journal 7 days ago

NONOF

NVO

JNJ
2 Top Dividend Stocks That Could Set You Up for Life

With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks. With that said, let's consider two top dividend stocks that should navigate the current storm relatively well and continue performing long after: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie went public in 2013, splitting from its former parent company, Abbott Laboratories.

Motley Fool 7 days ago

ABBV

GILD
AbbVie’s upadacitinib gains EU marketing authorisation for GCA

The authorisation was based on data from the multicentre Phase III SELECT-GCA trial.

Pharmaceutical Technology 8 days ago

ABBV
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis

European Commission approves ABBV's Rinvoq for its eighth indication, giant cell arteritis.

Zacks 8 days ago

ABBV

PFE
Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Investing.com -- Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading Eli Lilly (NYSE:LLY) to a Buy on strong growth prospects in obesity treatments.

Investing.com 8 days ago

LLY

PFE

ABBV
Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

Style Box ETF report for SCHD

Zacks 8 days ago

SCHW

ABBV

Performance Overview

Return	4AB.SG	S&P 500 (^GSPC)
YTD	-8.86%	-10.30%
1-Year	+2.55%	+5.05%
3-Year	+13.82%	+20.10%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AbbVie Inc (4AB.SG)

AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now

Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks

The Zacks Analyst Blog AbbVie, The TJX, The Charles Schwab, Enzo Biochem and CVD Equipment

Top Research Reports for AbbVie, TJX & Charles Schwab

AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In

The Zacks Analyst Blog Merck and AbbVie

ABBV vs. MRK: Which Drug Giant is a Better Buy Now?

The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis

Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?

Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More

Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know

Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan

Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs

2 Top Dividend Stocks That Could Set You Up for Life

AbbVie’s upadacitinib gains EU marketing authorisation for GCA

AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis

Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

Performance Overview